A large-scale study using data from China's Health and Retirement Longitudinal Study (CHARLS) from 2011 to 2020 paints a troubling picture of type 2 diabetes management, spotlighting how gender and income levels shape outcomes across the care continuum. Researchers analyzed over 11,000 to 14,000 adults per wave, tracking four key stages: prevalence, awareness, treatment, and control. 
What emerged were clear patterns of inequality that demand urgent fixes from healthcare leaders and physicians treating middle-aged and older patients. The results were published in Diabetes Research and Clinical Practice.
Prevalence Climbs Steeply, Women Hit Harder
Type 2 diabetes rates jumped dramatically over the decade, rising from 12.8% to 22.4% in women and from 12.0% to 21.5% in men. Women consistently faced higher odds of diagnosis, with adjusted odds ratios (aOR) ranging from 1.09 to 1.17 across the years. This gender gap held steady even after accounting for other factors, suggesting biological, lifestyle, or access issues play a role. 
Awareness Grows, Especially Among Women
Good news came in awareness levels, which improved noticeably over time, particularly for women who showed stronger gains (aOR: 1.18 to 1.31). Socioeconomic inequalities here narrowed, as measured by tools like the slope index of inequality (SII), relative index of inequality (RII), and concentration index (CIX). Low-income groups caught up somewhat in recognizing their condition, likely because of public health campaigns and better screening. 
Treatment Lags with Widening SES and Gender Gaps
The biggest red flag appeared in treatment, where over 60% of diagnosed patients went untreated throughout the period. Socioeconomic disparities persisted stubbornly, and they even widened for women, with RII values climbing from 1.22 to 1.45. Low-SES individuals, especially poorer women, faced the steepest barriers, perhaps due to costs, access to clinics, or competing priorities. Control rates, meanwhile, showed minimal differences by gender or SES.
Call for Targeted Action in China's Diabetes Fight
These findings urge physicians and policymakers to focus more on women and low-income patients, particularly boosting treatment uptake. Simple steps like subsidized medications, community clinics, and gender-sensitive education could close gaps. As China's diabetes burden swells and is projected to affect hundreds of millions, these disparities threaten to overwhelm healthcare systems unless addressed.